These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7684728)

  • 21. Structural and functional analysis of the S1 subunit of pertussis toxin using synthetic peptides.
    Chong P; Sydor M; Wu E; Zobrist G; Boux H; Klein M
    Mol Immunol; 1991 Mar; 28(3):239-45. PubMed ID: 2017195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of overlapping synthetic peptides covering the entire sequence of Haemophilus influenzae type b outer membrane protein P2.
    Chong P; Yang YP; Fahim R; McVerry P; Sia C; Klein M
    Infect Immun; 1993 Jun; 61(6):2653-61. PubMed ID: 8500904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
    Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
    Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of murine monoclonal antibodies that recognize defined epitopes of pertussis toxin and neutralize its toxic effect on Chinese hamster ovary cells.
    Walker MJ; Wehland J; Timmis KN; Raupach B; Schmidt MA
    Infect Immun; 1991 Nov; 59(11):4249-51. PubMed ID: 1718872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies to pertussis toxin: utilization as probes of toxin function.
    Kenimer JG; Kim KJ; Probst PG; Manclark CR; Burstyn DG; Cowell JL
    Hybridoma; 1989 Feb; 8(1):37-51. PubMed ID: 2466764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective activities in mice of monoclonal antibodies against pertussis toxin.
    Sato H; Sato Y
    Infect Immun; 1990 Oct; 58(10):3369-74. PubMed ID: 1698179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural relationship between the S1 and S4 subunits of pertussis toxin.
    Sato H; Sato Y
    FEMS Microbiol Lett; 1994 Jan; 115(1):63-9. PubMed ID: 7510256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune response to the B oligomer of pertussis toxin.
    Arciniega JL; Burns DL; Garcia-Ortigoza E; Manclark CR
    Infect Immun; 1987 May; 55(5):1132-6. PubMed ID: 3570457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with a multiple antigen peptide containing defined B- and T-cell epitopes: production of bactericidal antibodies against group B Neisseria meningitidis.
    Christodoulides M; Heckels JE
    Microbiology (Reading); 1994 Nov; 140 ( Pt 11)():2951-60. PubMed ID: 7529096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of pertussis toxin binding to model receptors by antipeptide antibodies directed at an antigenic domain of the S2 subunit.
    Schmidt MA; Schmidt W
    Infect Immun; 1989 Dec; 57(12):3828-33. PubMed ID: 2478479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune response to dimeric subunits of the pertussis toxin B oligomer.
    Hausman SZ; Burns DL; Sickler VC; Manclark CR
    Infect Immun; 1989 Jun; 57(6):1760-4. PubMed ID: 2722238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of polyclonal and monoclonal antibody responses to cholera toxin by the synthetic peptide approach.
    Ghose AC; Karush F
    Mol Immunol; 1988 Mar; 25(3):223-30. PubMed ID: 3374493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human antibody response to the B oligomer of pertussis toxin.
    Lynn F; Burnette WN; Siber GR; Arciniega JL
    Clin Diagn Lab Immunol; 1994 Nov; 1(6):626-32. PubMed ID: 8556512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mimicking of discontinuous epitopes by phage-displayed peptides, II. Selection of clones recognized by a protective monoclonal antibody against the Bordetella pertussis toxin from phage peptide libraries.
    Felici F; Luzzago A; Folgori A; Cortese R
    Gene; 1993 Jun; 128(1):21-7. PubMed ID: 7685299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological responses to the B subunit of Shiga-like toxin 1 and its peptide fragments indicate that the B subunit is a vaccine candidate to counter action of the toxin.
    Boyd B; Richardson S; Gariepy J
    Infect Immun; 1991 Mar; 59(3):750-7. PubMed ID: 1705242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of monoclonal antibody to pertussis toxin on toxin activity.
    Sato H; Sato Y; Ito A; Ohishi I
    Infect Immun; 1987 Apr; 55(4):909-15. PubMed ID: 2435660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface expression of a protective recombinant pertussis toxin S1 subunit fragment in Streptococcus gordonii.
    Lee SF; March RJ; Halperin SA; Faulkner G; Gao L
    Infect Immun; 1999 Mar; 67(3):1511-6. PubMed ID: 10024603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of native protein reactive antibodies by immunization with peptides containing linear B-cell epitopes defined by anti-porcine ZP3 beta monoclonal antibodies.
    Afzalpurkar A; Sacco AG; Yurewicz EC; Gupta SK
    J Reprod Immunol; 1997 Jun; 33(2):113-25. PubMed ID: 9234211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of a diphtheria toxin A fragment-C180 peptide fusion protein which elicits a neutralizing antibody response against diphtheria toxin and pertussis toxin.
    Barbieri JT; Armellini D; Molkentin J; Rappuoli R
    Infect Immun; 1992 Dec; 60(12):5071-7. PubMed ID: 1452339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map.
    De Magistris MT; Romano M; Bartoloni A; Rappuoli R; Tagliabue A
    J Exp Med; 1989 May; 169(5):1519-32. PubMed ID: 2469760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.